Results 71 to 80 of about 8,067 (167)

Simultaneous estimation of simvastatin and labetalol in bulk and solid dosage form

, 2019
A simple, accurate, precise, sensitive, and highly selective ultra violet spectrometer method has been developed for the simultaneous estimation of simvastatin and labetalol in bulk and solid dosage form.
Dangat, Sonali D., Bodke, Nikita N., Vishwakarma, Neha A., Sonawane, Abhijeet A., Phalke, Pooja K., Shinde, Akhil A., Jadhav, S.L.   +6 more
core   +1 more source

Formulation Development of Antihypertensive Drug Labetalol HCL Injection [PDF]

, 2019
Labetalol Hydrochloride Injection USP (Labetalol hydrochloride) is an adrenergic receptor blocking agent possessing both alpha1 (post-synaptic) and beta-receptor blocking activity.
Guru Prasad, A L
core  

消化器系の機能に対するLabetalolの影響

Influences of labetalol, an alpha and beta adrenoceptor blocking agent, on the function of mammalian digestive system were investigated. 1） Large amounts of labetalol （200 mg/kg, p.o., 10 mg/kg, i.v.） delayed gastrointestinal transit in mice.
大鹿, 英世, 八田, 慎一, 田中, 護, 竹村, 晴夫   +3 more
core  

Effects of intravenous nicardipine followed by oral labetalol in combination with nifedipine controlled-release tablet on severe peripartum hypertension

Objectives: To investigate the effects of intravenous nicardipine as initial therapy and oral labetalol combined with nifedipine controlled-release tablet as subsequent treatment of severe peripartum hypertension.
Qi, Haifeng; Department of Intensive Care Medicine, Chongqing Health Centre for Women and Children, Chongqing, China, Zhang, Yaozong; Department of Intensive Care Medicine, Chongqing Health Centre for Women and Children, Chongqing, China; Department of Intensive Care Medicine, Women and Children,s Hospital of Chongqing Medical University, Chongqing, China, Zhang, Ruoxuan; Department of Medicine, Harbin Medical University, Harbin, China, Li, Lan; Department of Intensive Care Medicine, Chongqing Health Centre for Women and Children, Chongqing, China, Lan, Lan; Department of Intensive Care Medicine, Chongqing Health Centre for Women and Children, Chongqing, China, Yan, Yunsheng; Department of Intensive Care Medicine, Chongqing Health Centre for Women and Children, Chongqing, China, Qin, Jiali; Department of Intensive Care Medicine, Chongqing Health Centre for Women and Children, Chongqing, China, Gan, Shengwen; Department of Intensive Care Medicine, Chongqing Health Centre for Women and Children, Chongqing, China   +7 more
core   +1 more source

Labetalol hepatotoxicity

The American Journal of Medicine, 1989
openaire   +2 more sources

Analysis, pharmacokinetics, metabolism and pharmacodynamics of labetalol in pregnant and nonpregnant sheep

, 1993
Labetalol, a combined al and p-adrenoceptor blocker, is used as an antihypertensive, especially in the management of hypertensive disorders in pregnancy.
Yeleswaram, Krishnaswamy
core  

Comparative maternal-fetal outcomes associated with different antihypertensive treatment strategies in preeclampsia: a retrospective cohort study. [PDF]

Front Pharmacol
Zhao L, Chen R, Xu Y, Wu H.
europepmc   +1 more source

Comparative evaluation of the effects of different doses of labetalol on cardiovascular response to tracheal intubation

, 2016
Background: This study aimed to determine the effects of different doses of labetalol on cardiovascular responses during tracheal intubation and to compare it with control group.
Keshavarzi, E., Kiani, N., Honarmand, A., Safavi, M.   +3 more
core  

Long-term cardiovascular risks in patients with hypertensive disorders of pregnancy treated with nifedipine or labetalol. [PDF]

Int J Cardiol Cardiovasc Risk Prev
Aggarwal P, Derti S, Yannamani A, Newman JS, Tuli R, Dargan P, Indaram M, Kassis-George H.   +7 more
europepmc   +1 more source

Comparison of labetalol and lidocaine in induction of controlled hypotension in tympanoplasty: a randomized clinical trial

Objectives: This study aimed to compare the efficacy of labetalol and lidocaine in tympanoplasty surgery, specifically evaluating their impact on hemodynamic changes and perioperative outcomes. Methods: A randomized controlled trial was conducted with 64
Zeinabsadat Fattahi Saravi, Reza Jahangiri, Naeimehossadat Asmarian, Hossein Hosseini, Mehdi Rahmati, Mahsa Banifatemi, Ali Karami   +6 more
core   +1 more source